Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
next (881)
,
subsequent (588)
Monoclonal antibody treatment for asthma - patient information
Description
Patient information factsheet Monoclonal antibody treatment for asthma We have sent you this factsheet because you are on the waiting list
Url
/Media/UHS-website-2019/Patientinformation/Respiratory/Monoclonal-antibody-treatment-for-asthma2320.pdf
VR-RituximabVenetoclax Cycle_2 Onwards
Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituximab Venetoc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf
Ibrutinib
Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Ibrutinib • CLL – Ibrutinib Indication • NICE TA 429 recommends ibrutinib alone
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib.pdf
Chlorambucil_7_Rituximab_Split
Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (7 day)-Rituximab (Split) Regimen • CLL – Chlorambucil (7 day)-Rituximab (Split) Indicat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7-Rituximab-Split.pdf
Chlorambucil_14_Rituximab_Split
Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (14 day)-Rituximab (Split) Regimen • CLL – Chlorambucil (14 day)-Rituximab (Split) Indic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14-Rituximab-Split.pdf
Acalabrutinib
Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indicati
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf
Paclitaxel (7 day)
Description
Chemotherapy Protocol BREAST CANCER PACLITAXEL (7 day) Regimen • Breast Cancer – Paclitaxel (7 day) Indication • Treatment of locally advanced or met
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-7-day.pdf
Gemcitabine ver1
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER GEMCITABINE Regimen Ovarian – Gemcitabine Indication The treatment of advanced ovarian cancer WHO Perfor
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Gemcitabine-ver1.pdf
Cisplatin Etoposide PO
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-ETOPOSIDE (Oral) Regimen Ovary-Cisplatin-Etoposide PO Indica
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CisplatinEtoposidePO.pdf
Cisplatin and Etoposide PO
Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CISPLATIN-ETOPOSIDE (oral) Regimen Uterine-Cisplatin-Etoposide PO Indi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/CisplatinEtoposidePO.pdf
311
to
320
of
1000
Previous
…
30
31
32
33
34
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.